In pancreatic adenocarcinoma, GATA6 directly binds to the DKK2-promotor leading to a down-regulation of its expression and, therefore, reduces its suppressive effect on the oncogenic Wnt pathways (Zhong et al. 2011). The gene discussed is GATA6; the disease is pancreatic adenocarcinoma.